In obese and T2DM animal models, low circulating levels of adiponectin impair the BCAAs catabolism, which leads to accumulation of these amino acids through a down-regulation of mitochondrial phosphatase 2C (PP2Cm) expression mediated by the AMPK signalling pathway [129]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.